↓ Skip to main content

Amurensin H, a Derivative From Resveratrol, Ameliorates Lipopolysaccharide/Cigarette Smoke–Induced Airway Inflammation by Blocking the Syk/NF-κB Pathway

Overview of attention for article published in Frontiers in Pharmacology, October 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Amurensin H, a Derivative From Resveratrol, Ameliorates Lipopolysaccharide/Cigarette Smoke–Induced Airway Inflammation by Blocking the Syk/NF-κB Pathway
Published in
Frontiers in Pharmacology, October 2019
DOI 10.3389/fphar.2019.01157
Pubmed ID
Authors

Yannan Fan, Ziqian Zhang, Chunsuo Yao, Jinye Bai, Hui Yang, Pei Ma, Yiyao Fan, Shuyi Li, Jiqiao Yuan, Mingbao Lin, Qi Hou

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 17%
Student > Master 2 11%
Professor > Associate Professor 1 6%
Professor 1 6%
Unknown 11 61%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 17%
Biochemistry, Genetics and Molecular Biology 2 11%
Agricultural and Biological Sciences 2 11%
Medicine and Dentistry 1 6%
Unknown 10 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2023.
All research outputs
#15,072,502
of 24,040,389 outputs
Outputs from Frontiers in Pharmacology
#5,106
of 17,886 outputs
Outputs of similar age
#195,138
of 353,357 outputs
Outputs of similar age from Frontiers in Pharmacology
#217
of 426 outputs
Altmetric has tracked 24,040,389 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,886 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,357 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 426 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.